FAIRFIELD, Conn., June 11, 2014 /PRNewswire/ -- Competitive
Technologies, Inc., (OTCQX: CTTC) (CTI) the pain
mitigation company, today announced that the Emmy® award
winning TV program "The Doctors" recently featured a medical
case involving a young patient living with Complex Regional Pain
Syndrome (CRPS) – a long-term chronic disease characterized by
severe chronic pain, swelling, and changes in the skin that often
worsens over time.
The show featured CTI's flagship product, the
Calmare® Pain Therapy device, as a non-invasive pain
therapy solution alternative instead of the large host of medicines
that Matthew currently uses to address the debilitating pain from
CRPS.
About the Segment on "Matthew" and CRPS
The segment
centered on the case of Matthew, the teenage son of Inside Edition
Chief Correspondent Jim Moret. Matthew sustained a foot injury
while playing soccer as a young child that progressed into CRPS.
His doctors have prescribed a large host of pain medications,
including LYRICA® (Pregabalin) and CYMBALTA®
(Duloxetine). In addition, Matthew has tried the gamut of
alternative therapies, such as acupuncture and Reiki, the Japanese
stress reduction technique involving the "laying of hands." To
date, no treatment has adequately treated his chronic pain
condition.
In their continuing effort of finding a better solution for
CRPS, the Moret family came to the show's studio's seeking advice
from their panel of doctors. In the episode, Dr. Travis Stork, M.D., an Emmy®
-nominated co-host of the award-winning talk show and a practicing
board-certified emergency medicine physician, offered the family
the opportunity to learn more about Calmare, a non-narcotic,
non-invasive procedure for the treatment of chronic pain.
Through a telephone link up with Dr. Jack
D'Angelo, M.D., a New York
City based physical medicine and rehabilitation specialist
at Calmare Pain Relief Solution, he offered some insights on how
Calmare Therapy works: "The Calmare device produces a 'no pain'
message, which is then transmitted to the affected nerve through
disposable surface electrodes that are applied to the skin
surrounding the region of the patient's pain. After completion of
multiple treatments, many patients are able to experience
long-lasting relief."
As a follow-up, Dr. Stork offered Matthew an opportunity to be
seen by one of the many centers in the U.S. now offering Calmare
Therapy to their patients.
To view the show, please visit:
http://www.thedoctorstv.com/videolib/init/11692
About the Company
Competitive Technologies Inc., the
pain mitigation company, develops and commercializes innovative
wound and pain management products and technologies. CTI holds the
510k clearance on its flagship product, the non-invasive
Calmare® Pain Therapy Device, which grants it an
exclusive right to sell, market, research and develop the medical
device. The Company is the exclusive licensed global distributor of
Calmare.
Forward-Looking Statement
Certain statements
contained in this press release are forward-looking statements that
involve risks and uncertainties. The statements contained herein
that are not purely historical are forward looking statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-looking statements deal with the Company's current
plans, intentions, beliefs and expectations and statements of
future economic performance. Forward-looking statements involve
known and unknown risks and uncertainties that may cause the
Company's actual results in future periods to differ materially
from what is currently anticipated. Factors that could cause or
contribute to such differences include those discussed from time to
time in reports filed by the Company with the Securities and
Exchange Commission. The Company cannot guarantee its future
results, levels of activity, performance or achievements.
Contacts: |
|
Competitive
Technologies,
Inc.
|
JV Public
Relations
|
Conrad Mir |
Janet
Vasquez
|
President and
CEO
|
Managing
Director
|
cmir@competitivetech.net |
jvasquez@jvprny.com |
973.798.8882
|
212.645.5498
|
www.competitivetech.net
Logo -
http://photos.prnewswire.com/prnh/20131015/NY97852LOGO
SOURCE Competitive Technologies, Inc.